At what enterprise value was MEDICX HEALTH acquired in 2023?

During the acquisition of MEDICX HEALTH by OPTIMIZERX in 2023, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 50M - 150M USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the TMT (Tech, Media, Telecom) industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of MEDICX HEALTH when it was acquired by OPTIMIZERX?

The exact EV/EBITDA multiple for MEDICX HEALTH is available on mynth capital. For comparison, the TMT (Tech, Media, Telecom) sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

When was MEDICX HEALTH acquired by OPTIMIZERX?

MEDICX HEALTH was acquired by OPTIMIZERX in 2023.

What was the revenue of MEDICX HEALTH at the time of the deal?

The revenue of MEDICX HEALTH at the time of the deal is estimated to be in the range of 25M - 50M USD. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the MEDICX HEALTH acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the MEDICX HEALTH deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://investors.optimizerx.com/news-releases/news-release-details/optimizerx-announces-agreement-acquire-medicx-health-95-million/

← DATABASE

Home Database TMT (Tech, Media, Telecom)MEDICX HEALTH

11/2023

MEDICX HEALTH acquired by OPTIMIZERX

UNITED STATES Software / AdTech EV 50M - 150M USD

Context

OptimizeRx agreed to acquire 100% of Medicx Health. The operation will be funded through a combination of existing cash, short-term investments, and proceeds from a new $40 million credit facility provided by Blue Torch Capital. Certain members of Medicx's management, including founder and CEO, committed to reinvesting approximately $10.5 million of their transaction proceeds into OptimizeRx common stock, aligning their interests with the combined entity's success. The strategic rationale centres on creating the most comprehensive healthcare marketing platform in the US by combining OptimizeRx's HCP-focused DAAP platform with Medicx's consumer-focused Micro-Neighborhood® Targeting Platform — thereby addressing both key stakeholders in pharmaceutical marketing (doctors and patients) through a single integrated technology ecosystem.

MEDICX HEALTH, which reported an EBITDA margin of LOGIN in 2022, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Medicx Health is a Scottsdale, Arizona-based healthcare consumer-focused omnichannel marketing and analytics company serving hundreds of life sciences brands. The company's core proprietary technology is its patented Micro-Neighborhood® Targeting Platform, built on its MX# advanced identity resolution technology, which enables highly precise, privacy-compliant targeting of both healthcare consumers and healthcare providers (HCPs) at the neighbourhood level. Medicx's platform supports life sciences brand and agency clients across the full commercial marketing cycle — from audience planning and omnichannel campaign execution (spanning advanced TV, programmatic digital display and video, social, digital radio) to closed-loop performance measurement, all within a single privacy-compliant environment.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2022

2021

Similar deals in TMT (Tech, Media, Telecom)

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
12/2023	SEPTEO	SEQUOIASOFT	FRANCE	Software	Septeo, a leading software publisher in Europe, announces the acquisition of the entire Sequoiasoft group (a software publisher for the hospitality industry). This acquisition allows the group to initiate sector diversification and accelerate its international presence, notably by establishing a significant foothold in Spain
12/2023	AMETHIS	CAPITAL BANKING SOLUTIONS	FRANCE	Software	Amethis acquired a majority stake in CBS in a primary LBO transaction. The investment is designed to support the group's expansion and to accelerate the technological shift of its software suite towards SaaS and cloud-native models
11/2023	21 INVEST	CONEX	FRANCE	Software	Conex, the leading French developer of customs and security management software, has opened its capital to 21 Invest France. This majority investment marks the second transaction of 21 Invest's sixth-generation fund
11/2023	OCEANSOUND PARTNERS	MESSAGE BROADCAST	UNITED STATES	Software	LINK Mobility has executed a strategic divestiture of its Message Broadcast subsidiary to focus on core operational priorities within the European market. This transaction aligns with the seller’s portfolio optimization strategy, aiming to improve earnings predictability by exiting a niche, weather-dependent segment with high revenue variability
11/2023	KEYSIGHT TECHNOLOGIES	ESI GROUP	FRANCE	Software	Keysight Technologies acquired 100% of ESI Group through a two-stage process. First, it purchased a 50.6% controlling block from the founding Rouvray family and historical shareholders at EUR155 per share
11/2023	DEVOLVER DIGITAL	SYSTEM ERA SOFTWORKS	UNITED STATES	Software	Devolver Digital has completed the 100% acquisition of System Era Softworks, Inc. The transaction involves a multi-part consideration structure including upfront cash and shares, along with deferred and performance-based earn-out components, reflecting the firm's focus on long-term alignment with the target's management team
11/2023	PSG EQUITY	DIAPASON	FRANCE	Software	Diapason, a premier French software vendor specializing in Treasury and Risk Management Systems (TRMS), has entered a new growth phase through a strategic partnership with PSG Equity. This transaction positions PSG as the majority shareholder, succeeding Seven2 (formerly Apax Partners Development), which had been an investor since 2020
11/2023	ARCHIMED	INSTEM	UNITED KINGDOM	Software	ARCHIMED has successfully completed the take-private acquisition of Instem, delisting the company from the London Stock Exchange (AIM). The transaction was driven by the need to liberate Instem from the short-term pressures of public reporting, allowing for more aggressive investment in long-term R&D
10/2023	CAPZA	TRAVELSOFT	FRANCE	Software	Capza invested nearly EUR100M to acquire a 13% stake (via preferred shares) and refinance the group's debt. This transaction allowed the exit of Andera Acto. The founder, Christian Sabbagh, remains the majority shareholder (>70%)
10/2023	SANDVIK	ESCO	GERMANY	Software	The transaction involves the 100% acquisition of esco GmbH by Sandvik AB, integrating the target's specialized power skiving software into the acquirer’s Manufacturing and Machining Solutions division

REFERENCES

Valuation range: EV 50M - 150M USD

Revenue range: 25M - 50M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDICX HEALTH by OPTIMIZERX are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).